R. Antonelou

发表

Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study

M. Stamelou, P. Barone, I. Beratis, 2021, medRxiv.

Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease

M. Stamelou, L. Stefanis, H. Michelakakis, 2017, Neuroscience Letters.

Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.

M. Stamelou, I. Beratis, S. Papageorgiou, 2021, Journal of Parkinson's disease.

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study.

M. Stamelou, I. Beratis, S. Papageorgiou, 2021, Parkinsonism & related disorders.

Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.

M. Stamelou, I. Beratis, S. Papageorgiou, 2020, Journal of Parkinson's disease.

Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients

M. Stamelou, M. Xilouri, L. Stefanis, 2015, Movement disorders : official journal of the Movement Disorder Society.

Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene.

M. Stamelou, G. Koutsis, S. Papageorgiou, 2017, Parkinsonism & related disorders.

Clinical differences between early-onset and mid-and-late-onset Parkinson's disease: Data analysis of the Hellenic Biobank of Parkinson's disease

M. Stamelou, N. Scarmeas, D. Vassilatis, 2022, Journal of the Neurological Sciences.

The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.

M. Stamelou, N. Scarmeas, D. Vassilatis, 2019, Parkinsonism & related disorders.

Motor and Nonmotor Features of Carriers of the p.A53T Alpha‐Synuclein Mutation: A Longitudinal Study

M. Stamelou, S. Papageorgiou, L. Stefanis, 2016, Movement disorders : official journal of the Movement Disorder Society.

Decreased levels of alpha‐synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis

L. Stefanis, Evangelia Emmanouilidou, K. Voumvourakis, 2015, Journal of neurochemistry.

APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population

I. Beratis, Nikolaos Andronas, S. Papageorgiou, 2022, Geriatrics.

TGF-β/BMPs: Crucial crossroad in neural autoimmune disorders

S. Tsiodras, E. Stamboulis, D. Kitsos, 2011, Neurochemistry International.

Evolving Causes of Rapidly Progressive Dementia

G. Tsivgoulis, S. Papageorgiou, L. Stefanis, 2021, Alzheimer disease and associated disorders.

Apathy: an underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.

M. Stamelou, I. Beratis, S. Papageorgiou, 2021, medRxiv.

Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease

M. Stamelou, T. Gasser, C. Schulte, 2022, medRxiv.

Title Page Title: Apathy: an underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Running title: Apathy in prodromal Parkinson’s disease

M. Stamelou, I. Beratis, S. Papageorgiou, 2021 .

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report

C. Potagas, I. Beratis, S. Papageorgiou, 2023, Medicina.

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review

M. Stamelou, I. Pachi, L. Stefanis, 2023, Genes.

Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review.

M. Stamelou, C. Potagas, S. Papageorgiou, 2024, Neurology international.